Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLA2G15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SFT2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPIRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC14L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928255 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HECTD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6125 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCF2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINGO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LLGL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF818P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on